Clinical trial
Phase II Study of Short-course Radiotherapy With Induction and Consolidation Chemotherapy in Patients With Locally Advanced High-risk Rectal Cancer
NCT04674696 is registered in ClinicalTrials.gov with Instituto Nacional de Cancer, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Short-course Radiotherapy With Induction and Consolidation Chemotherapy in Patients With Locally Advanced High-risk Rectal Cancer
- Lead sponsor
- Instituto Nacional de Cancer, Brazil
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 10, 2020
- Completion date
- June 30, 2022
- Enrollment
- 54 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer, total neoadjuvant treatment